About the Company

QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide. On May 8, 2020 the U.S. Food and Drug Administration (FDA) has issued the first emergency use authorization (EUA) for a COVID-19 antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs.

Sector

Life Sciences

Industry

In Vitro & In Vivo Diagnostic Substances

Employees

1500

Exchange

Nasdaq